Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smartphone Optical Sensor Diagnoses Kaposi's Sarcoma

By LabMedica International staff writers
Posted on 27 Jun 2013
A smartphone-based system has been created for in-the-field detection of the herpes virus that causes Kaposi's sarcoma, a type of cancer linked to Acquired Immunodeficiency Syndrome (AIDS).

The system consists of a plug-in optical accessory and disposable microfluidic chips, and the technique could also be adapted for use in detecting a range of other conditions, from Escherichia coli infections to hepatitis. More...


Biomedical engineers at Cornell University (Ithaca, NY, USA) devised and used the smartphones for diagnostic testing, which unlike other methods, this system is chemically based and does not use the phone's built-in camera. Instead, gold nanoparticles are combined or conjugated with short DNA snippets that bind to Kaposi's DNA sequences, and a solution with the combined particles is added to a microfluidic chip.

In the presence of viral DNA, the particles clump together, which affects the transmission of light through the solution. This causes a color change that can be measured with an optical sensor connected to a smartphone via a micro-USB (universal serial bus) port. The nanoparticle solution is a bright red when little or no Kaposi's virus DNA is present, but at higher concentrations, the solution turns a duller purple, providing a quick method to quantify the amount of Kaposi's DNA. The main advantage of the system compared to previous Kaposi's detection methods is that users can diagnose the condition with little training.

David Erickson, PhD, who devised the technique said, “The accessory provides an ultraportable way to determine whether or not viral DNA is present in a sample.” Matthew Mancuso, a doctoral student in Prof. Erickson’s laboratory added, “The smartphone reader could also work with other color-changing reactions, such as the popular enzyme-linked immunosorbent assays (ELISA), a common tool in medicine to test for human immunodeficiency virus (HIV), hepatitis, food allergens, and E. coli. The laboratory has also created smartphone accessories for use with the color-changing strips in pH and urine assays. These accessories could form the basis of a simple, at-home, personal biofluid health monitor.” The study was presented at the Conference on Lasers and Electro Optics held June 9-14, 2013, in San Jose (CA, USA).

Related Links:

Cornell University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.